Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Laser Scanning Microplate Cytometer

By Drug Discovery Trends Editor | June 24, 2010

mirrorballTTP LabTech will showcase its Mirrorball high sensitivity laser scanning microplate cytometer for antibody discovery at BioExpo Japan, 30 June – 2 July 2010. Alongside the on-stand viewing of Mirrorball, TTP LabTech will also be presenting supporting performance data in its workshop ‘Mix-and-Read Screening for Antibody Discovery’, on July 2nd from 2-2.30pm, room EX-B4.

Mirrorball is the first microplate cytometer to offer simultaneous laser scanning, enabling superior multiplexing and resulting in higher throughput single pass scanning. Filling a critical role by rapidly and reliably performing mix-and–read, cell- or bead-based assays, Mirrorball is set to revolutionise the antibody discovery process.

Dr Wayne Bowen, Chief Scientific Officer at TTP LabTech, comments on the strategy behind Mirrorball. “Innovation is key to success at TTP LabTech and we have an exceptional team onboard who provide this. Additionally, we listen, and incorporate feedback from the scientific community into our R&D process.” He continued, “By listening to the needs of researchers in antibody discovery, we have been able to respond with a novel and advanced technology which is Mirrorball – a unique high sensitivity microplate cytometer for fluorescence cellular screening.”

TTP LabTech


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE